If you haven’t done so already, check NIAID’s Clinical Trial Research page and confirm whether your planned research meets NIH’s definition of a clinical trial. Then read this page for NIAID’s unique requirements for investigator-initiated clinical trials (IICTs).
Table of Contents
- Follow the NIAID IICT Process
- What To Do If You Need an Extension After Award
- IICT Resources for Staff and Applicants
To apply for your own clinical trial outside of NIAID’s Networks, you must follow NIAID’s rules and process for IICTs as described below. Otherwise, we will not accept your application.
Start with NIAID’s Investigator-Initiated Clinical Trial Planning and Implementation Awards SOP, then read the following:
- Investigator-Initiated Clinical Trial Awards—General Questions and Answers and other IICT Questions and Answers
- Four Tips for Investigator-Initiated Clinical Trial Applications
Decide which FOA best suits your research:
- NIH Research Project Grant (Parent R01, Clinical Trial Required)— best for clinical trials that are not high-risk*
- NIH Exploratory/Developmental Research Grant Program (Parent R21, Clinical Trial Required)—best for mechanistic or investigative studies
- NIAID Clinical Trial Implementation Cooperative Agreement (U01, Clinical Trial Required)—best for clinical trials that are high-risk*
- NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44, Clinical Trial Required)—the only choice for small businesses
*For the NIAID definition of high risk, see How do I determine level of risk and choose an award type for my application?
If you need support to get ready for the launch of an IICT, such as planning, designing, and preparing the documentation necessary for implementing an IICT, consider applying first for an NIAID Clinical Trial Planning Grant (R34, Clinical Trial Not Allowed). An R34 is not a prerequisite for any other clinical trial award.
Then, at least 10 weeks before your application’s due date, speak to the scientific/research contact listed on the FOA to request a prior consultation.
The purpose of this consultation is four-fold:
- Assure you that your proposed clinical trial meets NIAID’s goals, fits within our mission, and addresses a high priority research area
- Determine the risk level of your proposed trial
- Review the information and documents you’ll need to include in your application
- Identify other mechanisms to support your clinical trial, e.g., through a different funding opportunity announcement or one of our clinical trial networks
Prepare for that discussion using our guide, Requesting Prior Consultation to Discuss Submission of a NIAID Clinical Trial Application.
Last, write your application and gather all documentation you’ll need when you apply. Learn more and get advice from NIAID:
- What’s Special About Clinical Trial Applications?
- Four Things To Do Before You Apply for an Investigator-Initiated Clinical Trial
If you can't complete a clinical trial by the end of the award, you may be able to apply for an extension. For NIAID policy on extending an IICT, read the following pages:
- Investigator-Initiated Clinical Trial Administrative Extensions SOP
- Investigator-Initiated Clinical Trial Administrative Extensions Questions and Answers
In addition to the websites noted above, we have the following resources to help you with your application:
- Requesting Prior Consultation to Discuss Submission of a NIAID Clinical Trial Application
- Investigator-Initiated Clinical Trial Planning and Implementation Awards SOP
- Investigator-Initiated Clinical Trials Questions and Answers
- Types of Funding Opportunities
- Research Using Human Subjects. Includes IRB and assurance information
- Checklists for Planning and Writing a Human Subjects Grant Application
- Apply for a Grant. Advice on how to plan and write an application and manage a grant
- NIAID Clinical Terms of Award
- Guidance for Compliance on using the Terms
- Rules and Policies for Clinical Research
- ClinRegs—for country-specific clinical research regulatory information, including comparison information, presented in plain language
- Human Subjects Warning
- Sample Letter to Document Training in the Protection of Human Subjects
- Research Methods Resources
We also advise you to review NIAID’s clinical research policies. These policies may differ somewhat depending on your research and topic area.